Zuari Agro Chemicals Limited has informed the Exchange about General Updates
ZUARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zuari Agro Chemicals' board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025, with the statutory auditor issuing an unmodified (clean) opinion. On a standalone basis, the company swung to a net loss of Rs 73.10 crore in FY25 versus a profit of Rs 21.40 crore in FY24, with Q4 FY25 alone posting a Rs 22.85 crore loss. On a consolidated basis, PAT rose about 35% to Rs 230.96 crore on revenue of Rs 4,490.37 crore, helped by a Rs 150.33 crore share of profit from joint venture Paradeep Phosphates. The auditor flagged emphasis-of-matter paragraphs on three issues: a SEBI show cause notice (Jan 2025) on alleged past financial irregularities, for which the company has filed a settlement application; MCFL's disputed Rs 29.14 crore urea subsidy recognition pending in the Delhi High Court; and the proposed MCFL–PPL merger scheme. The board also approved transfer of 2,90,37,000 MCFL shares to ZMPPL for Rs 418.14 crore, re-appointment of an independent director for 3 years, and appointment of new cost, internal, and secretarial auditors.
Mixed picture for shareholders: consolidated earnings are strong and growing on the back of the PPL joint venture, but the standalone business is loss-making and faces a regulatory overhang from the SEBI show cause notice. The Mahad plant shutdown due to raw material shortage and the ongoing MCFL subsidy and merger matters add near-term uncertainty, though the clean audit opinion and ongoing settlement process limit immediate downside risk.